Simplex Trading’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,630
Closed -$137K 9403
2025
Q2
$116K Sell
5,630
-57,846
-91% -$1.19M ﹤0.01% 5087
2025
Q1
$1.24M Buy
+63,476
New +$1.33M ﹤0.01% 2492
2024
Q4
Sell
-2,170
Closed -$47.7K 8925
2024
Q3
$52K Buy
+2,170
New +$58K ﹤0.01% 5845
2024
Q2
Sell
-951
Closed -$27K 9149
2024
Q1
$28K Sell
951
-450
-32% -$13.2K ﹤0.01% 6806
2023
Q4
$44K Buy
+1,401
New +$44K ﹤0.01% 6197
2023
Q3
Sell
-121
Closed -$4.61K 9064
2023
Q2
$4K Buy
+121
New +$4.82K ﹤0.01% 8035
2023
Q1
Sell
-4,027
Closed -$155K 9405
2022
Q4
$170K Buy
4,027
+4,016
+36,509% +$165K ﹤0.01% 4422
2022
Q3
$0 Sell
11
-1,083
-99% -$38K ﹤0.01% 10262
2022
Q2
$35K Buy
1,094
+174
+19% +$5.64K ﹤0.01% 6946
2022
Q1
$33K Buy
920
+882
+2,321% +$30.3K ﹤0.01% 7660
2021
Q4
$1K Sell
38
-1,964
-98% -$81.9K ﹤0.01% 10189
2021
Q3
$83K Hold
2,002
﹤0.01% 6881
2021
Q2
$81K Buy
2,002
+1,003
+100% +$38.7K ﹤0.01% 7032
2021
Q1
$32K Buy
+999
New +$37.6K ﹤0.01% 7062

Other funds holding GMAB

Simplex Trading's GMAB Position: Q3 2025 in Review

Simplex Trading sold out of Genmab (GMAB) in Q3 2025, closing a stake of 5,630 shares — an estimated $137K sold.

Simplex Trading first reported a position in GMAB in Q1 2021 and held it in 14 quarters. The position peaked at $1.24M in Q1 2025. 252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Simplex Trading reported no remaining Genmab position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 5,630 Genmab shares in Q3 2025, an estimated $137K.
  • Simplex Trading first reported a position in Genmab in Q1 2021 and held it in 14 quarters.
  • Simplex Trading's Genmab position peaked at $1.24M in Q1 2025.
  • 252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.